Strategies to achieve high-value oncology care—a beginning
Menée aux Etats-Unis par entretiens auprès de médecins oncologues, cette étude analyse l'association entre leur conception de la qualité des soins, leurs pratiques thérapeutiques et les dépenses de santé pour les patients atteints de cancer
Cancer care is costly for individuals and in the aggregate. In one study, insured patients with advanced cancer reported median monthly out-of-pocket treatment expenditures of $592.1 In the aggregate, US expenditures for cancer care were $127 billion in 2013, which was 7% of total health care expenditures.2 These costs are projected to be at least $158 billion in 2020.3 Cancer care contributed 6.5% of the growth in health expenditures from 2000 to 2013. Circulatory diseases provide an informative contrast: disability-adjusted life-years have shrunk nearly 20% from 2005 to 2010 while annual expenditures have increased 7%. For cancer, the same figures are 12% and 26%, respectively.2
JAMA Oncology , commentaire, 2016